Oyak Yatirim Menkul Degerler A.S. (IST:OYYAT)

Oncternal Therapeutics Revenue

In the year 2024, Oyak Yatirim Menkul Degerler A.S. had annual revenue of 22.53B TRY, down -34.31%. Oyak Yatirim Menkul Degerler A.S. had revenue of 10.74B in the quarter ending December 31, 2024, a decrease of -27.28%.

• Revenue: 22.53B
• Revenue Growth: -34.31%
• P/S Ratio: 0.53
• Revenue / Employee: 76.62M
• Employees: 294
• Market Cap: 11.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	22.53B	-11.76B	-34.31%
Dec 31, 2023	34.29B	-14.54B	-29.78%
Dec 31, 2022	48.83B	8.23B	20.27%
Dec 31, 2021	40.60B	20.87B	105.76%
Dec 31, 2020	19.73B	3.41B	20.88%